LXH254

LXH254

Cat. No.: DIA-0230616

Size: 50 mg Size: 500 mg Size: Customer Size
Product Information
CAS No. 1800398-38-2
Formula C25H25F3N4O4
Molecular Weight 502.49
SMILES CC1=CC=C(NC(=O)C2=CC(=NC=C2)C(F)(F)F)C=C1C3=CC(=NC(=C3)OCCO)N4CCOCC4
Product Description LXH254 is a type II ATP-competitive inhibitor that inhibits both B- and CRAF kinase activities at picomolar concentrations with a high degree of selectivity against a panel of 456 human kinases and in cell-based assays.
Format & Storage
Purity > 99%
Shipping Shipped on dry ice.
Storage Powder: -20 °C, 3 years; 4 °C, 2 years In solvent: -80 °C, 6 months; -20 °C, 1 month
Solubility Overview Soluble in DMSO
All of our services and products are intended for preclinical research use only and cannot be used to diagnose, treat or manage patients.
logo

Ace Therapeutics has a team of experts in the field of endocrine and metabolic research, aiming to provide innovative preclinical contract research solutions to cope with diabetes and its complications. We provide customized solutions and technical support, enabling the transformation of promising concepts into innovative treatments, thus accelerating the drug development process of diabetes.

Quick Links
Contact Info
Copyright © Ace Therapeutics. All Rights Reserved.
Top